SCHEMBL24938531

SCHEMBL24938531

CCCCCC/C=C\CCCCCCCC(=O)C(F)(F)F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 12/20 1.00
CES1 P23141 7/20 1.00
MAPT P10636 2/20 0.81
BLM P54132 2/20 0.81
ALDH1A1 P00352 1/20 0.81
PLA2G4B P0C869 1/20 0.81
PLA2G4A P47712 1/20 0.81
MGLL Q99685 1/20 0.81
PLA2G4C Q9UP65 1/20 0.81
CES2 O00748 2/20 0.78
CYP1A2 P05177 2/20 0.78
HSD17B10 Q99714 2/20 0.78
MEN1 O00255 1/20 0.78
KMT2A Q03164 1/20 0.78
TERT O14746 2/20 0.61
GMNN O75496 1/20 0.61
USP2 O75604 1/20 0.61
LMNA P02545 1/20 0.61
POLB P06746 1/20 0.61
CYP2C9 P11712 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27204763 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL8059738 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL8066150 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL8049506 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL4085369 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL24938529 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL4085373 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL24939095 1.00 FAAH (1.00) FAAHCES1MAPTBLMALDH1A1
SCHEMBL29038500 0.96 FAAH (0.93) FAAHCES1MAPTBLMALDH1A1
SCHEMBL2849161 0.96 FAAH (0.93) FAAHCES1MAPTBLMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230023267-A1 OLEIC ACID DERIVATIVES AS TREATMENTS FOR FRIEDREICH ATAXIA AND INHIBITORS OF FERROPTOSIS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230023267-A1 OLEIC ACID DERIVATIVES AS TREATMENTS FOR FRIEDREICH ATAXIA AND INHIBITORS OF FERROPTOSIS AIFM2, ACOX1, ALOX12 FAAH 232/4885CES1 2527/4885MAPT 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.